Asura

Asuragen, Inc. is a leading innovator in the fields of Genetics, Oncology, and Companion Diagnostics (CDx) Development. With a unique blend of proprietary chemistries and advanced bioinformatics, Asuragen addresses critical testing needs in modern medicine. Their diverse product portfolio includes specialized kits like the AmplideX® series, which provides essential tools for testing various genetic conditions and cancers, such as Fragile X Syndrome and Chronic Myeloid Leukemia (CML).

Asuragen is committed to transforming complex health data into actionable insights for physicians, researchers, patients, and families, ensuring they receive the best possible information to guide treatment decisions. The company emphasizes collaboration and a culture of innovation, fostering an environment where creativity is celebrated and customer needs are prioritized. With a dedication to community engagement and a team of passionate professionals, Asuragen strives to improve human health outcomes through scientific advancement and meaningful diagnostics. Asuragen believes that people deserve better answers, and they are relentless in their pursuit of this mission.